• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Cytosorbents Cor (NQ: CTSO )

    0.9300 +0.0350 (+3.91%)
    Streaming Delayed Price Updated: 4:00 PM EST, Nov 18, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 71,190
    Open 0.8950
    Bid (Size) 0.9003 (10)
    Ask (Size) 0.9500 (15)
    Prev. Close 0.8950
    Today's Range 0.8950 - 0.9714
    52wk Range 0.7000 - 2.150
    Shares Outstanding 54,679,569
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    CytoSorbents And Converge Biotech Announce Strategic Partnership to Expand Sepsis and Critical Care Treatment with CytoSorb in India
    From CytoSorbents; Converge Biotech
    Via GlobeNewswire
    CytoSorbents Reports Third Quarter 2024 Financial and Operational Results
    From CytoSorbents
    Via GlobeNewswire

    Performance

    YTD
    -13.08%
    -13.08%
    1 Month
    -11.43%
    -11.43%
    3 Month
    -11.43%
    -11.43%
    6 Month
    -5.04%
    -5.04%
    1 Year
    -33.57%
    -33.57%

    More News

    Read More
    CytoSorbents Submits Health Canada Medical Device License Application for DrugSorb-ATR Following MDSAP Certification
    From CytoSorbents
    Via GlobeNewswire
    Analyst Scoreboard: 5 Ratings For CytoSorbents
    Via Benzinga
    Expert Outlook: CytoSorbents Through The Eyes Of 5 Analysts
    Via Benzinga
    FDA Accepts DrugSorb-ATR De Novo Application To Reduce the Severity of CABG-Related Bleeding Due to Ticagrelor and Initiates Substantive Review
    From CytoSorbents
    Via GlobeNewswire
    CytoSorbents to Report Third Quarter 2024 Operating and Financial Results
    From CytoSorbents
    Via GlobeNewswire
    CytoSorbents Submits DrugSorb-ATR Marketing Application to U.S. FDA to Reduce the Severity of Bleeding in Heart Bypass Surgery Patients on the Blood Thinner Ticagrelor and Provides Business Update
    From CytoSorbents
    Via GlobeNewswire
    CytoSorbents to Present at the H.C. Wainwright 26ᵗʰ Annual Global Investment Conference
    From CytoSorbents
    Via GlobeNewswire
    CytoSorbents Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From CytoSorbents
    Via GlobeNewswire
    CTSO Stock Earnings: CytoSorbents Beats EPS, Beats Revenue for Q2 2024
    Via InvestorPlace
    CytoSorbents Reports Second Quarter 2024 Financial and Operational Results
    From CytoSorbents
    Via GlobeNewswire
    CytoSorbents Appoints Peter J. Mariani Chief Financial Officer
    From CytoSorbents
    Via GlobeNewswire
    CytoSorbents to Report Second Quarter 2024 Operating and Financial Results
    From CytoSorbents
    Via GlobeNewswire
    CytoSorbents Announces Compliance with Nasdaq Minimum Bid Price Requirement
    From CytoSorbents
    Via GlobeNewswire
    CytoSorbents Unveils Newly Redesigned, Unified Company and Product Website
    From CytoSorbents
    Via GlobeNewswire
    CytoSorbents to Present at the Inaugural American Association of Physicians of Indian Origin (AAPI) World Health Congress
    From CytoSorbents
    Via GlobeNewswire
    Why CytoSorbents (CTSO) Stock Is Trading Higher
    Via Benzinga
    CytoSorbents Secures $20 Million Credit Facility
    From CytoSorbents
    Via GlobeNewswire
    CytoSorbents Announces Regulatory Approval of CytoSorb® in Taiwan
    From CytoSorbents
    Via GlobeNewswire
    CytoSorbents Announces the Launch and Immediate Availability of the PuriFi™ Blood Pump in the European Union
    From CytoSorbents
    Via GlobeNewswire
    CytoSorbents to Host its 2024 Virtual Annual Stockholders Meeting
    From CytoSorbents
    Via GlobeNewswire
    CytoSorbents STAR Registry Data on Patients on Ticagrelor Undergoing CABG Surgery with CytoSorb Presented at EuroPCR 2024. Named Top Five Finalist for Best Scientific Abstract
    From CytoSorbents
    Via GlobeNewswire
    CTSO Stock Earnings: CytoSorbents Meets EPS, Beats Revenue for Q1 2024
    Via InvestorPlace
    CytoSorbents Reports First Quarter 2024 Results
    From CytoSorbents
    Via GlobeNewswire
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.